OFOtto Jesus Hernandez Fustes

Otto Jesus Hernandez Fustes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Otto Jesus Hernandez Fustes has a total of 132 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Historical Perspectives on Spinocerebellar Ataxia Type 2: The Cuban Contribution

    by Otto Jesus Hernandez Fustes, Carlos Arteaga Rodriguez, Hélio Afonso Ghizoni Teive

    Spinocerebellar ataxia type 2 (SCA2) is one of the most extensively investigated hereditary ataxias worldwide. Although the first clinical description of the disorder was reported in India in 1971 by Wadia and Swami, the province of Holguín, Cuba subsequently became recognized as a major geographical focus of SCA2, with a particularly high concentration of affected families and individuals, where it became internationally recognized as Cuban ataxia. Since the late 1970s, Cuban investigators have played a pivotal role in the clinical, epidemiological, neuropathological, and genetic characterization of the disorder. This article presents a historical review of the scientific development of Cuban ataxia based on a comprehensive bibliographic and documentary analysis, complemented by interviews with key neurologists involved in its early investigation. Particular emphasis is placed on the pioneering contributions of José Rafael Estrada González, Lionel Valles Calaña, Guillermo Orozco Díaz, and Luis Velázquez Pérez, whose work established the foundations for the current understanding of SCA2. Their investigations culminated in the identification of one of the world's largest SCA2 clusters and substantially advanced knowledge of the disease's clinical spectrum, epidemiology, and molecular genetics. The Cuban experience illustrates how sustained clinical observation, multidisciplinary collaboration, and international partnerships transformed a regional neurological disorder into one of the best‐characterized hereditary ataxias worldwide. © 2026 International Parkinson and Movement Disorder Society.

  • Thalamic dysconnection and sensorimotor impairment in SCA10

    by Léo Coutinho, Alex Tiburtino Meira, Walter Oleschko Arruda, Carlos Henrique Ferreira Camargo, Otto Jesus Hernandez Fustes, Hélio A. Ghizoni Teive

  • Open Access

    Amyotrophic lateral sclerosis (ALS): new insights 156 years after Charcot's masterful description

    by Otto Jesus Hernandez Fustes, Hélio Afonso Ghizoni Teive

    In 1869, Charcot and Alix Joffroy published the first detailed clinical and neuropathological description of amyotrophic lateral sclerosis (ALS), establishing the correlation involving muscle weakness, atrophy, spasticity, and degeneration of the lateral corticospinal tracts. Charcot unified the involvement of upper and lower motor neurons into a single clinical entity. His pioneering description was limited to the motor system, reflecting the scientific constraints of his time. Charcot interpreted ALS primarily as a disorder of the motor system, a conclusion consistent with the clinical and pathological methods available in the late nineteenth century. Neurological investigation at that time relied mainly on detailed clinical observation, anatomical correlation at autopsy, and relatively-simple physiological techniques. These approaches were well suited to identify motor dysfunction but were far less capable of revealing subtle cognitive or behavioral alterations. Currently, ALS is recognized as a multisystem neurodegenerative disorder. Thus, Charcot's historical contribution was crucial for the initial understanding of ALS, while modern perspectives acknowledge its broader clinical complexity beyond the motor system.

  • Open Access

    The skin-wrinkling test: principles and clinical applications

    by Otto Jesus Hernández Fustes, Cláudia Suemi Kamoi Kay, Paulo José Lorenzoni, Renata Dal-Prá Ducci, Paula Raquel Do Vale Pascoal Rodrigues, Orlando Graziani Povoas Barsottini, Rosana Herminia Scola

    Cutaneous wrinkling is a normal phenomenon that occurs on the palms in a reversible manner and results from vasoconstriction influenced by vasomotor function. It can be assessed through the skin-wrinkling test following water immersion, with the absence or reduction of wrinkling being associated with disorders affecting the dense network of sympathetic nerves in these regions. The literature suggests that this test may serve as a screening tool for small-fiber neuropathy, particularly in settings in which biopsy is not available. It is a rapid, inexpensive, and easily-accessible test. We herein review the principles of the skin-wrinkling test, its pathophysiology, and its clinical indications as a tool to evaluate the sympathetic component of the autonomic nervous system.

  • Open Access

    Clinical profile and quality of life in late-onset and very-late-onset myasthenia gravis: a cross-sectional study

    by Alessandra Filpo Ferreira da Silva, Cláudia Suemi Kamoi Kay, Renata Dal-Prá Ducci, Paula Raquel Do Vale Pascoal Rodrigues, Otto Jesus Hernandez Fustes, Paulo José Lorenzoni, Rosana Herminia Scola

    The incidence of late-onset and very-late-onset myasthenia gravis (MG) has increased worldwide, but national data in Brazil remain scarce. Characterizing the clinical profile and quality of life (QoL) of these patients is essential to improve care strategies. To describe the clinical profile and assess QoL of patients with late- and very-late-onset MG followed at a Brazilian tertiary hospital, comparing them with early-onset MG patients. Cross-sectional observational study including adult MG patients followed at a tertiary university hospital. Demographic, clinical, serological, neurophysiological, and radiological data were collected. Disease severity was assessed using the Myasthenia Gravis Composite (MGC) and Quantitative Myasthenia Gravis (QMG) scales. Furthermore, QoL was assessed using the 15-item Myasthenia Gravis QoL questionnaire (MG-QOL15). Correlation analyses were performed between MG-QOL15, MGC, and QMG scores. In total, 28 MG patients were included: 13 early-onset, 7 late-onset, and 8 very-late-onset. Male predominance, shorter disease duration, and absence of thymectomy were more frequent in the late and very-late-onset groups. These subgroups also showed better symptom control and perceived QoL, particularly the very-late-onset group. The MG-QOL15 scores showed a moderate correlation with MGC and a weaker correlation with QMG. Late-onset and very-late-onset MG patients showed satisfactory QoL and clinical profiles, consistent with international data. These correlations reinforce the complementary role of patient-reported outcomes alongside objective clinical scales. Further studies with larger cohorts and longitudinal follow-up are needed.

  • Open Access

    Somatosensory Evoked Potentials in Spinocerebellar Ataxia Type 3 and Type 10

    by Léo Coutinho, Otto Jesus Hernandez Fustes, Carlos Henrique Ferreira Camargo, Gabriel Abrahão Stoliar, Francisco Manoel Branco Germiniani, Salmo Raskin, Tetsuo Ashizawa, Cláudia Suemi Kamoi Kay, Paulo José Lorenzoni, Renata Dal-Prá Ducci, et al.

    Spinocerebellar ataxias (SCAs) are heterogeneous neurodegenerative disorders with variable phenotypes. Somatosensory evoked potentials (SSEPs) provide insights into the integrity of the dorsal-lemniscal pathway. This study aimed to evaluate SSEP findings in patients with SCA3 and SCA10 and compare their neurophysiological profiles. We conducted a cross-sectional study including 20 SCA3 patients and 20 SCA10 patients under follow-up at a tertiary ataxia clinic in Southern Brazil. Clinical assessment comprised demographic, genetic, and phenotypic characterization, including the Scale for the Assessment and Rating of Ataxia (SARA). SSEPs were recorded bilaterally after median and tibial nerve stimulation, assessing latencies and amplitudes of N9, N20, N21, and P40 potentials, as well as interpotential intervals. Examinations were classified as normal or abnormal, and abnormalities were categorized. Abnormal SSEPs were detected in 18 SCA3 patients (90%) and in 3 SCA10 patients (15%) ( p < 0.001). In SCA3, abnormalities predominantly involved central generators. In contrast, most SCA10 patients exhibited normal SSEPs, with only a few isolated cortical responses and interval abnormalities. No significant associations were found between SSEP abnormalities and demographic, clinical, imaging, or genetic variables in either group. SCA3 shows widespread somatosensory dysfunction, whereas SCA10 patients, particularly in Southern Brazil, show preserved SSEPs consistent with pure cerebellar ataxia. These findings highlight distinct neurophysiological signatures in SCAs, reinforcing their heterogeneity and supporting SSEPs as candidate markers for differential characterization, requiring validation.


  • Open Access

    Prevalence and predictors of low bone mineral density in Myasthenia gravis

    by Renata Dal-Prá Ducci, Lucas Ferreira Santana, Claudia Kamoi Kay, Raphael Henrique Déa Cirino, Paulo José Lorenzoni, Otto Jesus Hernandez Fustes, Paula Raquel Do Vale Pascoal Rodrigues, Carolina Aguiar Moreira, Rosana Hermínia Scola

    Myasthenia gravis (MG) is an autoimmune disease affecting the postsynaptic neuromuscular junction. Treatment often includes corticosteroids, which may reduce bone mass. To evaluate the prevalence and predictors of low bone mineral density (BMD) in MG patients. A cross-sectional study included patients over 18 years with MG followed at the Neuromuscular Diseases Service, Hospital de Clínicas, Universidade Federal do Paraná (2018–2022). Data were obtained through clinical evaluation, medical records, MG Composite Scale, and Quantitative MG Test. Lumbar spine and proximal femur BMD were assessed using a GE Lunar densitometer, with T or Z-scores according to age/menopausal status. Logistic regression identified factors independently associated with BMD alterations. In total, 92 patients (64.1% female, mean age: 51.3 years) were included, of whom 79.3% had early-onset MG. Past or present corticosteroid use were reported in 94.5 and 45.6%, respectively. Only 27.6% practiced regular physical activity, though most had adequate calcium intake. There were six (7.8%) patients with fragility fractures, and ⅕ were at high fracture risk according to the FRAX results. We found that BMD alterations occurred in 43.5% of patients. No significant association was found with corticosteroid use or MG severity. Age was independently associated with BMD (OR = 1.06, 95% CI: 1.03–1.09, p = 0.0005). A cutoff age ≥ 49 years yielded 82.5% sensitivity, 63.5% specificity, and an area under the ROC curve of 0.72 (95% CI: 0.61–0.83). Reduced BMD is frequent in MG, highlighting the importance of screening and prevention of low bone mass, osteoporosis, and fragility fractures, particularly in patients over 49 years, regardless of corticosteroid use or MG severity.

  • Somatosensory evoked potentials in neuromyelitis optica spectrum disorders

    by Otto Jesus Hernandez Fustes, Cláudia Suemi Kamoi Kay, Paulo José Lorenzoni, Renata Dal-Pra Ducci, Lineu Cesar Werneck, Rosana Herminia Scola

    Neuromyelitis optica spectrum disorders (NMOSD) are rare antibody-mediated disorders of the central nervous system with a predilection for the spinal cord and optic nerves. Our objective is to evaluate the dorsolemniscal system using the somatosensory evoked potential, specifically the registration of the N20 and P40 waves. The Somatosensory evoked potentials (SSEP) were prospectively performed in 13 patients with NMOSD. All the patients were recruited from the outpatient clinic of a demyelinating diseases center from Southern Brazil. We evaluated 12 female with mean age of 42 years-old and one man of 25 years-old. When categorized in relation to the variable SSEP (Normal vs. Abnormal), there was a statistical difference in relation to N20, N21 and P40 latencies. SSEP showed a significant increase in N20 and P40 latencies. SSEP is a non-invasive, painless, fast and low-cost exam which provides neurophysiological data for diagnosis of NMOSD.

  • Open Access

    Outcome and Quality of Life in Guillain–Barré Syndrome in Southern Brazil

    by Giuliana Pipolo, Lara Santos Godoy, Eduardo Hummelgen, Carlos Arteaga Rodriguez, Otto Jesus Hernandez Fustes

    Background: Guillain–Barré Syndrome (GBS) is an acute immune‐mediated polyradiculoneuropathy with an annual incidence of 0.4 per 100,000 inhabitants in Brazil. Clinical manifestations range from mild weakness to tetraplegia with respiratory failure. Objective: To analyze the impact on the quality of life of adult patients diagnosed with GBS in the short and medium term. Methods: This regional descriptive, cross‐sectional study included 46 hospitalized patients with confirmed GBS. Functional status was measured using the overall disability sum score (ODSS), and quality of life was evaluated with the WHOQOL‐BREF instrument. Results: During the study period, 57 patients were diagnosed with GBS; 11 met exclusion criteria, and 5 died, yielding a mortality rate of 8.7%. All deceased patients were older than 55 years (mean 59,6 p = 00, 008) and presented with respiratory failure. Higher Hughes scores at admission (mean 3.8 vs. 2.75; p = 0.039) and longer duration of antecedent symptoms (24.33 vs. 14.80 days; p = 0.036)were significantly associated with mortality. Moderate/high‐risk mEGOS scores were present in 80% of deceased patients ( p = 0.008). Quality of life perceptions improved most between 6 and 12 months postdiagnosis, while functional recovery (ODSS) was observed after 12 months. Conclusion: Higher admission neurological disability was associated with greater functional impairment in this cohort, while quality of life improved during follow‐up and functional recovery continued beyond 12 months. Higher Hughes scores and moderate‐to‐high mEGOS risk were associated with mortality in univariable analyses, but the small number of deaths and absence of multivariable adjustment preclude conclusions regarding independent prognostic effects. Extended follow‐up is important to capture the gradual trajectory of functional and psychosocial recovery in GBS.